Effect of Botulinum Toxin Type A on Morphology of Salivary Glands in Patients with Cerebral Palsy

다국어 초록 (Multilingual Abstract)

Objective To investigate the eff ect of botulinum toxin type A (BTXA) on drooling and the morphologic change of the salivary gland in patients with cerebral palsy.
Method Eight cerebral palsy patients suffering from severe drooling participated in this study. BTXA was injected into both submandibular and parotid glands under intravenous sedation and with ultrasound guidance (1 unit/gland/kg: maximum 100 units) in an outpatient or inpatient procedure. The severity of drooling was measured before injection and 3 weeks after injection using the Teacher Drooling Scale, the Drooling Score-severity,frequency and the Visual Analog Scale. To investigate the morphologic change of the salivary glands, the size of salivary glands were measured before injection and 3 weeks after injection using computed tomography of the neck. The measurement values were analyzed by Wilcoxon signed rank test.
Results Statistically significant improvements were shown in all three parameters for assessing the severity of drooling after BTXA injections (p<0.05). Size of the salivary glands were signifi cantly decreased at 3 weeks after BTXA injection (p<0.05).
Conclusion Salivary gland injection with BTXA could be a useful treatment method to reduce drooling in patients with cerebral palsy and decreased size of salivary glands may partially explain the mechanism.

참고문헌 (Reference)

1 박희원, "뇌성마비 환아의 침 흘림 실태 조사" 대한재활의학회 31 (31): 535-540, 2007

2 Bachrach SJ, "Use of glycopyrrolate and other anticholinergic medication for sialorrhea in children with cerebral palsy" 37 : 485-490, 1998

3 Jongerius PH, "The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy" 41 : 351-353, 2005

4 Jongerius PH, "The treatment of drooling by ultrasoundguided intraglandular injections of botulinum toxin type A into the salivary glands" 113 : 107-111, 2003

5 Ekedahl C, "Surgical treatment of drooling" 77 : 215-220, 1974

6 van der Burg JJ, "Social interaction and selfesteem of children with cerebral palsy after treatment for severe drooling" 165 : 37-41, 2006

7 Bushara KO, "Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment botulinum toxin A injections of the parotid glands" 48 : 337-339, 1997

8 Heo MS, "Quantitative analysis of normal major salivary glands using computed tomography" 92 : 240-244, 2001

9 Tahmassebi JF, "Prevalence of drooling in children with cerebral palsy attending special schools" 45 : 613-617, 2003

10 Banerjee KJ, "Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy" 48 : 883-887, 2006

11 Gisel EG, "Oral-motor skills following sensorymotor therapy in two groups of moderately dysphagic children with cerebral palsy: aspiration vs nonaspiration" 11 : 59-71, 1996

12 Savarese R, "Intraparotid injection of botulinum toxin A as a treatment to control sialorrhoea in children with cerebral palsy" 3 : 304-311, 2004

13 Teymoortash A, "Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells" 152 : 161-167, 2007

14 Coskun BU, "Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat" 264 : 783-787, 2007

15 Harris SR, "Drooling and its management in cerebral palsy" 29 : 807-811, 1987

16 Suskind DL, "Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy" 112 : 73-81, 2002

17 Dressler D, "Botulinum toxin: mechanisms of action" 63 : 180-185, 2005

18 Bhatia KP, "Botulinum toxin is a useful treatment in excessive drooling in saliva" 67 : 697-, 1999

19 Jongerius PH, "Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series" 160 : 509-512, 2001

20 Pena AH, "Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration" 20 : 368-373, 2009

21 Dressler D, "Adib Saberi F. Botulinum toxin: mechanisms of action" 53 : 3-9, 2005

22 Jongerius PH, "A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling" 88 : 911-914, 2003